• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD8 T 细胞对呼吸道病毒感染的免疫反应

The CD8 T Cell Response to Respiratory Virus Infections.

机构信息

Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA, United States.

Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, United States.

出版信息

Front Immunol. 2018 Apr 9;9:678. doi: 10.3389/fimmu.2018.00678. eCollection 2018.

DOI:10.3389/fimmu.2018.00678
PMID:29686673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5900024/
Abstract

Humans are highly susceptible to infection with respiratory viruses including respiratory syncytial virus (RSV), influenza virus, human metapneumovirus, rhinovirus, coronavirus, and parainfluenza virus. While some viruses simply cause symptoms of the common cold, many respiratory viruses induce severe bronchiolitis, pneumonia, and even death following infection. Despite the immense clinical burden, the majority of the most common pulmonary viruses lack long-lasting efficacious vaccines. Nearly all current vaccination strategies are designed to elicit broadly neutralizing antibodies, which prevent severe disease following a subsequent infection. However, the mucosal antibody response to many respiratory viruses is not long-lasting and declines with age. CD8 T cells are critical for mediating clearance following many acute viral infections in the lung. In addition, memory CD8 T cells are capable of providing protection against secondary infections. Therefore, the combined induction of virus-specific CD8 T cells and antibodies may provide optimal protective immunity. Herein, we review the current literature on CD8 T cell responses induced by respiratory virus infections. Additionally, we explore how this knowledge could be utilized in the development of future vaccines against respiratory viruses, with a special emphasis on RSV vaccination.

摘要

人类极易感染呼吸道病毒,包括呼吸道合胞病毒(RSV)、流感病毒、人偏肺病毒、鼻病毒、冠状病毒和副流感病毒。虽然有些病毒只会引起普通感冒的症状,但许多呼吸道病毒在感染后会引起严重的细支气管炎、肺炎,甚至死亡。尽管临床负担巨大,但大多数最常见的肺部病毒缺乏长效有效的疫苗。目前几乎所有的疫苗接种策略都是为了诱导广泛中和抗体,以预防随后感染引起的严重疾病。然而,许多呼吸道病毒的黏膜抗体反应并不持久,并且随着年龄的增长而下降。CD8 T 细胞对于介导肺部许多急性病毒感染后的清除至关重要。此外,记忆 CD8 T 细胞能够提供针对二次感染的保护。因此,联合诱导病毒特异性 CD8 T 细胞和抗体可能提供最佳的保护性免疫。本文综述了呼吸道病毒感染诱导的 CD8 T 细胞反应的最新文献。此外,我们探讨了如何利用这些知识开发针对呼吸道病毒的未来疫苗,特别强调 RSV 疫苗接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e22/5900024/c3b3ef8ddf2d/fimmu-09-00678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e22/5900024/c3b3ef8ddf2d/fimmu-09-00678-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e22/5900024/c3b3ef8ddf2d/fimmu-09-00678-g001.jpg

相似文献

1
The CD8 T Cell Response to Respiratory Virus Infections.CD8 T 细胞对呼吸道病毒感染的免疫反应
Front Immunol. 2018 Apr 9;9:678. doi: 10.3389/fimmu.2018.00678. eCollection 2018.
2
Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.尽管人偏肺病毒感染期间可诱导产生功能性CD8+ T细胞,但肺部CD8+ T细胞仍会出现功能损伤。
J Virol. 2015 Sep;89(17):8713-26. doi: 10.1128/JVI.00670-15. Epub 2015 Jun 10.
3
Persistence in Temporary Lung Niches: A Survival Strategy of Lung-Resident Memory CD8 T Cells.在临时肺微环境中的持久性:肺驻留记忆CD8 T细胞的一种生存策略
Viral Immunol. 2017 Jul/Aug;30(6):438-450. doi: 10.1089/vim.2017.0016. Epub 2017 Apr 18.
4
Viral acute lower respiratory infections impair CD8+ T cells through PD-1.病毒引起的急性下呼吸道感染通过 PD-1 抑制 CD8+ T 细胞。
J Clin Invest. 2012 Aug;122(8):2967-82. doi: 10.1172/JCI62860. Epub 2012 Jul 17.
5
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.含有呼吸道合胞病毒F蛋白的病毒样颗粒疫苗通过调节树突状细胞和效应T细胞的特定亚群提供无肺部疾病的保护。
J Virol. 2015 Nov;89(22):11692-705. doi: 10.1128/JVI.02018-15. Epub 2015 Sep 9.
6
Pulmonary immunity to viruses.肺部对病毒的免疫
Clin Sci (Lond). 2017 Jun 30;131(14):1737-1762. doi: 10.1042/CS20160259. Print 2017 Jul 15.
7
CD8+ T cell immunity against human respiratory syncytial virus.针对人类呼吸道合胞病毒的CD8 + T细胞免疫
Vaccine. 2014 Oct 21;32(46):6130-7. doi: 10.1016/j.vaccine.2014.08.063. Epub 2014 Sep 16.
8
A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.单次鼻腔内给予病毒样颗粒疫苗可有效保护小鼠免受人类呼吸道合胞病毒感染。
Antiviral Res. 2017 Aug;144:57-69. doi: 10.1016/j.antiviral.2017.05.005. Epub 2017 May 18.
9
Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8 T-cell immunity against respiratory syncytial virus infection.基于重组杆状病毒的 M2 蛋白疫苗可诱导针对呼吸道合胞病毒感染的保护性 CD8 T 细胞免疫。
J Microbiol. 2017 Nov;55(11):900-908. doi: 10.1007/s12275-017-7306-6. Epub 2017 Oct 27.
10
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.蛋白质降解增加可改善体外流感病毒核蛋白特异性CD8+T细胞活化,但在C57BL/6小鼠中则不然。
J Virol. 2016 Oct 28;90(22):10209-10219. doi: 10.1128/JVI.01633-16. Print 2016 Nov 15.

引用本文的文献

1
Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy.重组严重急性呼吸综合征冠状病毒2疫苗中壳聚糖、脂质纳米颗粒和明矾佐剂的比较分析:对其免疫原性和血清学效力的评估
Vaccines (Basel). 2025 Jul 24;13(8):788. doi: 10.3390/vaccines13080788.
2
T Cell Responses to Influenza Infections in Cattle.牛对流感感染的T细胞反应。
Viruses. 2025 Aug 14;17(8):1116. doi: 10.3390/v17081116.
3
Immunomodulation in Respiratory Syncytial Virus Infection: Mechanisms, Therapeutic Targets, and Clinical Implications.

本文引用的文献

1
Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.记忆性 CD8 T 细胞介导呼吸道合胞病毒感染后的严重免疫病理。
PLoS Pathog. 2018 Jan 2;14(1):e1006810. doi: 10.1371/journal.ppat.1006810. eCollection 2018 Jan.
2
Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8 T-cell immunity against respiratory syncytial virus infection.基于重组杆状病毒的 M2 蛋白疫苗可诱导针对呼吸道合胞病毒感染的保护性 CD8 T 细胞免疫。
J Microbiol. 2017 Nov;55(11):900-908. doi: 10.1007/s12275-017-7306-6. Epub 2017 Oct 27.
3
Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy.
呼吸道合胞病毒感染中的免疫调节:机制、治疗靶点及临床意义
Microorganisms. 2025 Aug 12;13(8):1876. doi: 10.3390/microorganisms13081876.
4
A Lymphocyte Subset-Based Prediction Model for Refractory Community-Acquired Pneumonia in Immunocompetent Patients.免疫功能正常患者难治性社区获得性肺炎基于淋巴细胞亚群的预测模型
Diagnostics (Basel). 2025 Jun 26;15(13):1627. doi: 10.3390/diagnostics15131627.
5
In Vitro Characterization of the Immune Response to an Epitope Ensemble Vaccine Against Rhinovirus in Pediatric Asthma and Adults With Chronic Obstructive Pulmonary Disease: Protocol for an Observational and Exploratory Study.针对小儿哮喘和慢性阻塞性肺疾病成人患者的鼻病毒表位组合疫苗免疫反应的体外特征:一项观察性和探索性研究方案
JMIR Res Protoc. 2025 Jun 30;14:e73383. doi: 10.2196/73383.
6
SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与长期新冠——第1部分:刺突蛋白在长期新冠综合征病理生理机制中的影响
Viruses. 2025 Apr 25;17(5):617. doi: 10.3390/v17050617.
7
Pathogenicity and virulence of lumpy skin disease virus: A comprehensive update.结节性皮肤病病毒的致病性和毒力:全面更新
Virulence. 2025 Dec;16(1):2495108. doi: 10.1080/21505594.2025.2495108. Epub 2025 Apr 27.
8
Deep insight into cytokine storm: from pathogenesis to treatment.深入洞察细胞因子风暴:从发病机制到治疗。
Signal Transduct Target Ther. 2025 Apr 16;10(1):112. doi: 10.1038/s41392-025-02178-y.
9
Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus - virus-like particles for pulmonary delivery.评估双病原体识别受体激动剂作为呼吸道合胞病毒-病毒样颗粒肺部给药佐剂的效果。
Front Immunol. 2025 Mar 17;16:1561297. doi: 10.3389/fimmu.2025.1561297. eCollection 2025.
10
Regulation of respiratory CD8+ T-cell immunity by suppressive monocyte-like dendritic cells (MCs).抑制性单核细胞样树突状细胞(MCs)对呼吸道CD8 + T细胞免疫的调节
J Immunol. 2025 May 1;214(5):977-994. doi: 10.1093/jimmun/vkae059.
人偏肺病毒的免疫分析用于靶向免疫疗法的开发
J Infect Dis. 2017 Sep 15;216(6):678-687. doi: 10.1093/infdis/jix358.
4
Reduced generation of lung tissue-resident memory T cells during infancy.婴儿期肺组织驻留记忆T细胞生成减少。
J Exp Med. 2017 Oct 2;214(10):2915-2932. doi: 10.1084/jem.20170521. Epub 2017 Aug 30.
5
Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity.流感诱导的肺驻留记忆T细胞动态变化是异源亚型免疫力下降的基础。
Sci Immunol. 2017 Jan 6;2(7). doi: 10.1126/sciimmunol.aag2031.
6
Airway T cells protect against RSV infection in the absence of antibody.气道 T 细胞在没有抗体的情况下可预防 RSV 感染。
Mucosal Immunol. 2018 Jan;11(1):249-256. doi: 10.1038/mi.2017.46. Epub 2017 May 24.
7
Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance.肺组织驻留记忆性CD8+ T细胞在组织再生部位的特定微环境可实现不依赖CD69的维持。
J Exp Med. 2016 Dec 12;213(13):3057-3073. doi: 10.1084/jem.20160938. Epub 2016 Nov 4.
8
Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection.疫苗产生的肺部组织驻留记忆 T 细胞为流感感染提供了异源保护。
JCI Insight. 2016 Jul 7;1(10). doi: 10.1172/jci.insight.85832.
9
Multiple Inhibitory Pathways Contribute to Lung CD8+ T Cell Impairment and Protect against Immunopathology during Acute Viral Respiratory Infection.多种抑制性途径导致肺部CD8 + T细胞功能受损,并在急性病毒性呼吸道感染期间预防免疫病理损伤。
J Immunol. 2016 Jul 1;197(1):233-43. doi: 10.4049/jimmunol.1502115. Epub 2016 Jun 3.
10
Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.经鼻内给予表达呼吸道合胞病毒(RSV)抗原的巨细胞病毒(MCMV)可在肺部引发强大的组织驻留效应性和效应记忆性CD8 + T细胞。
Mucosal Immunol. 2017 Mar;10(2):545-554. doi: 10.1038/mi.2016.48. Epub 2016 May 25.